This is a decommissioned version of ERA which is running to enable completion of migration processes. All new collections and items and all edits to existing items should go to our new ERA instance at https://ualberta.scholaris.ca - Please contact us at erahelp@ualberta.ca for assistance!
Communities and Collections
Usage
- 192 views
- 256 downloads
Melatonin for cognitive impairment (Protocol)
-
- Author(s) / Creator(s)
-
This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective is a systematic review of evidence relating to clinical efficacy and safety of melatonin in treatment of manifestations of dementia or cognitive impairment (CI).
-
- Date created
- 2002
-
- Subjects / Keywords
-
- Type of Item
- Article (Published)
-
- License
- © 2002 The Cochrane Collaboration for John Wiley & Sons, Ltd. This version of this article is open access and can be downloaded and shared. The original author(s) and source must be cited.